Association of British HealthTech Industries

Perimeter Medical Imaging AI Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 29, 2023
Mayo Clinic, Certified Management Accountant, Surgeon, CMA, Meta, University, International, International Accounting Standards Committee, Classification, Baylor College of Medicine, London Business School, Principal investigator, Clinical trial, Baylor University, Perimeter, Master, Sloan Fellows, FSE, Management science, ID, InterAction Council of Former Heads of State and Government, Baptists, Patient, International Financial Reporting Standards, Engineering, OCT, OTC, Webcast, CFO, Association of British HealthTech Industries, IAS, FDA, PINK, Medtech, International Accounting Standards Board, Management, Medical device, Cryptocurrency, DALLAS, Science

TORONTO and DALLAS, Aug. 29, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its second quarter ended June 30, 2023 and provided a corporate update.

Key Points: 
  • TORONTO and DALLAS, Aug. 29, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its second quarter ended June 30, 2023 and provided a corporate update.
  • In addition, I am pleased to report that Sara Brien will become Perimeter's Chief Financial Officer, effective September 1, 2023.
  • The study is evaluating the use of Perimeter B-Series OCT combined with its proprietary ImgAssist AI software during breast conservation surgery.
  • The Company will host a conference call and live audio webcast today, Tuesday, August 29, 2023, at 5:00 pm Eastern Time to discuss its second quarter 2023 results and to provide a corporate update.

Better Life Partners Raises $26.5 Million in Series B Financing to Amplify and Scale its Hybrid Whole-Health Solutions for Substance Use Disorders

Retrieved on: 
Tuesday, August 29, 2023
Minter, United States Navy, Suds, Better Life, The Better Life, MBA, MD, Patient, Capital, SUD, Association of British HealthTech Industries, BLP, Health, Death, Pharmaceutical industry, Nursing, Management

Better Life Partners will use the new capital to further develop and scale its effective, technology-enabled care model for people with substance use disorders, while also expanding its population management services in new and existing markets.

Key Points: 
  • Better Life Partners will use the new capital to further develop and scale its effective, technology-enabled care model for people with substance use disorders, while also expanding its population management services in new and existing markets.
  • Better Life Partners has raised $38 million since its founding in 2018 by Adam Groff MD and Steve Kelly.
  • Unfortunately, millions of Americans today remain without true cost-effective access to addiction treatment, resulting in avoidable illness and, all too often, death.
  • Better Life Partners uses a model that leverages community-embedded, high-access engagement, married with purpose-built technology and alternative-payment models, to drive effective and replicable outcomes across populations.

ALERT: The M&A Class Action Firm Continues Investigating the Merger – HT, ABCM, THRN, SURF

Retrieved on: 
Monday, August 28, 2023
HT, Danaher Corporation, Abcam, Empire, Sale, NYSE, Monteverde, Association of British HealthTech Industries, Hersha Hospitality Trust, KSL Capital Partners, Security (finance)

Under the terms of the agreement, HT shareholders are expected to receive $10.00 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, HT shareholders are expected to receive $10.00 in cash per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, ABCM shareholders are expected to receive $24.00 in cash per share they own.
  • Surface Oncology, Inc. (Nasdaq: SURF ), relating to its proposed sale to Coherus BioSciences, Inc. Click here for more information: https://www.monteverdelaw.com/case/surface-oncology-inc .

Bonfire Analytics, an AI-driven sales intelligence platform, closes pre-seed round

Retrieved on: 
Monday, August 28, 2023
Association of British HealthTech Industries, Data science, CRMS, Machine learning, Cryptocurrency, Retail

Bonfire Analytics is a company that enables digital health, medical device, and biotech organizations to identify qualified leads through machine learning and analytics.

Key Points: 
  • Bonfire Analytics is a company that enables digital health, medical device, and biotech organizations to identify qualified leads through machine learning and analytics.
  • By knowing which providers match ideal customers from the start, sales teams can maximize their sales efficiency.
  • The practice of ‘spraying and praying’ or sending thousands of emails to prospective clients and hoping for a response is no longer needed with Bonfire Analytics.
  • Utilizing Bonfire Analytics’ insights is much simpler than working with competing products since the platform is specifically designed to assist healthtech sales teams selling to providers & plans.

Tri Ri Asset Management Announces Final Close Of Oversubscribed VC Fund At $142m

Retrieved on: 
Friday, August 25, 2023
Banking, Asset Management, Professional Services, Finance, Fintech, Face, Association of British HealthTech Industries, Information technology, Government, FDI, Investment, TRAM, Ecosystem, VC, Security (finance), Cryptocurrency, Science, KPK

Tri Ri Asset Management (“ TRAM ”), a New York based Asset Manager, has announced the final close of its flagship $142m TRAM Venture Fund (“TRAM VF” or “the fund”), which closed at its ‘hard cap’.

Key Points: 
  • Tri Ri Asset Management (“ TRAM ”), a New York based Asset Manager, has announced the final close of its flagship $142m TRAM Venture Fund (“TRAM VF” or “the fund”), which closed at its ‘hard cap’.
  • The final close of the fund witnessed participation from two pension funds, a sovereign wealth fund, and leading Scandinavian & Swiss based family offices.
  • The anchor investment was drawn from TRAM Impact Fund I.
  • The fund focused on MENA with a particular interest in Pakistan, plans to invest in startups, with valuations ranging from $10m to $100m.

Bonfire Analytics, an AI-driven lead generation platform, closes pre-seed round with over one million in investment

Retrieved on: 
Thursday, August 24, 2023
Association of British HealthTech Industries, Data science, CRMS, Machine learning, Cryptocurrency, Commercial property, Sales

Bonfire Analytics is a company that enables digital health, medical device, and biotech organizations to identify qualified leads through machine learning and analytics.

Key Points: 
  • Bonfire Analytics is a company that enables digital health, medical device, and biotech organizations to identify qualified leads through machine learning and analytics.
  • The practice of ‘spraying and praying’ or sending thousands of emails to prospective clients and hoping for a response is no longer needed with Bonfire Analytics.
  • Lead scores and claims-based targeting can also be accessed directly through commonly used CRMs since Bonfire Analytics has built-in integrations.
  • Bonfire Analytics was founded by Vinay Nagaraj and Jaya Pokuri in 2022 to resolve the inefficient process of lead generation in healthtech.

TurnCare partners with Monetize360 to effectively scale its Patient Management Solution, driving revenue and increasing customer satisfaction

Retrieved on: 
Wednesday, August 23, 2023
Cloud, Intelligence Support Battalion, Internet of things, Hospital, Hospital-acquired infection, Johnson Health Tech, Patient management software, Blood, Association of British HealthTech Industries, Patient, LOS, Nursing, 3D printing

LOS ALTOS, Calif., Aug. 23, 2023 /PRNewswire-PRWeb/ -- TurnCare has selected Monetize360, a leading Agile Monetization company, to drive, support, and enable utilization-driven billing data capture for their first-of-its-kind Intelligent Support Surface Patient Management Solution. The company chose Monetize360 because of its singular ability to handle the challenges of complex, usage-based billing models at scale without requiring intensive engineering resources.

Key Points: 
  • The company chose Monetize360 because of its singular ability to handle the challenges of complex, usage-based billing models at scale without requiring intensive engineering resources.
  • Hospitals only pay for TurnCare when they use it for specific patients.
  • With an intuitive front end, almost anyone within TurnCare can analyze revenue in moments instead of days to weeks.
  • Since deploying Monetize360, we've seen a significant uptick in revenue and increased customer satisfaction.

Psilera Awarded Tampa Bay HealthTech Company of the Year and Finalists for Company to Watch by GrowFL

Retrieved on: 
Wednesday, August 23, 2023
Growth, Association of British HealthTech Industries, Entrepreneurship, Tampa Bay area, Research, American City Business Journals, Airline

TAMPA, Fla., Aug. 23, 2023 /PRNewswire/ -- Psilera, a biopharmaceutical company delivering next-generation mental health treatments at home, is thrilled to announce they have been recognized by both the Tampa Bay Business Journal (TBBJ) and the GrowFL group for their commitment to innovative research and their ability to stand out in a competitive market.

Key Points: 
  • Psilera has established itself as a key player in the biopharmaceutical industry.
  • The TBBJ has recognized Psilera as the Tampa Bay Inno Awards honoree of the year in the HealthTech category.
  • The Tampa Bay Inno Awards showcase the startups and entrepreneurs elevating the Tampa Bay Area as a new leading hub of innovation.
  • Psilera's selection as the HealthTech standout is a testament to the company's focus on designing novel neurological drugs leveraging its AI/machine learning-assisted platform, Psilera Third Eye.

Fenwick's New 'Closing Time' Podcast Demystifies Healthcare Startups

Retrieved on: 
Thursday, August 10, 2023
Pulse, Amazon Music, Closing time, Columbia Business School, Association of British HealthTech Industries, Apple Podcasts, Spotify

"I'm thrilled to leverage my experience as a successful founder and investor to inform hard-driving conversations that can inspire and guide the entrepreneurs shaping the future of healthcare," said Tecco, who founded three healthcare startups and teaches at the Columbia Business School.

Key Points: 
  • "I'm thrilled to leverage my experience as a successful founder and investor to inform hard-driving conversations that can inspire and guide the entrepreneurs shaping the future of healthcare," said Tecco, who founded three healthcare startups and teaches at the Columbia Business School.
  • "And there's no better firm than Fenwick to partner with on such a comprehensive and entertaining crash course in digital health."
  • "The decision to launch 'Closing Time' was inspired by a simple principle: Go where your audience is," said Esquivel, who co-leads Fenwick's healthtech practice.
  • Check out the trailer and subscribe today on Spotify , Apple Podcasts , Amazon Music or anywhere else podcasts are available.

The Future of Fertility Financing: How Sunfish is changing the fertility industry to focus on successful pregnancies, not treatments

Retrieved on: 
Thursday, August 3, 2023
Fintech, Pregnancy, Society, Pharmacy, Parent, Anxiety, Association of British HealthTech Industries, St. Louis Fed Financial Stress Index, Multimedia, Reproductive endocrinology and infertility, Practice, IVF, Assisted reproductive technology, Patient, Family, Data science, Birth control, Sunfish

Sunfish announces today that it has launched a new year-long membership program, which includes a custom financial plan with IVF treatment package costs for each member.

Key Points: 
  • Sunfish announces today that it has launched a new year-long membership program, which includes a custom financial plan with IVF treatment package costs for each member.
  • What's groundbreaking: this membership guarantees a refund of up to 90% of the treatment costs if the financial plan underestimates the costs to become pregnant.
  • "Boston IVF is pleased to offer the innovative Sunfish program to reduce the financial burden for patients," he states.
  • Sunfish is not a registered financial planner or advisor, lender, insurer, medical or healthcare provider and does not provide medical advice.